Intravitreal Ranibizumab (Lucentis®) for Neovascular Glaucoma- a Randomized Controlled Study
Clinical trial NCT02914626 · UNKNOWN
Trial details
- NCT number
- NCT02914626
- Sponsor
- LEANDRO CABRAL ZACHARIAS
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-01
- Primary completion
- 2017-10-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.